GGrantIndex
Sort

166,118 grants matching stem cells

Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation

$715,303
Karen Leslie Syrjala · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

Heart Digital Twin Analysis of Arrhythmias due to Infiltrating Adiposity

$715,300
Natalia A. Trayanova · Johns Hopkins University · R01 · FY2025 · HL

Regulation of NF-Kappa B

$715,263
Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2011 · AI

Delineating mechanisms underlying azole-induced developmental toxicity using single cell transcriptomic approaches, genome editing tools, and alternative models

$715,222
Joshua Frederick Robinson · University Of California, San Francisco · R01 · FY2022 · ES

Molecular mechanism of thyroid hormone receptor function during metamorphosis

$715,219
Yun-Bo Shi · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Inflammatory Organ Injury after Pneumonia-Derived Sepsis

$715,216
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2025 · AI

Inflammatory Organ Injury after Pneumonia-Derived Sepsis

$715,216
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2024 · AI

Epigenetic regulation of pulmonary smooth muscle cell remodeling in Pulmonary Hypertension

$715,161
Margaret A Schwarz · Indiana University Indianapolis · R56 · FY2023 · HL

Lineages and pathophysiology of clonal histiocytic disorders

$715,157
Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2017 · HL

Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential

$715,156
Peter W Laird · Van Andel Research Institute · R01 · FY2020 · CA

Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential

$715,156
Peter W Laird · Van Andel Research Institute · R01 · FY2021 · CA

hiPSC Cardiomyocyte HTS Electrophysiology System for Detecting Drug Induced Fatal Cardiac Arrhythmias

$715,140
Todd Joseph Herron · Cartox, Llc · R44 · FY2019 · ES

Development of Novel Immunotherapeutic Strategies for Myeloid Malignancies

$715,080
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Center for Regenerative Medicine (CRM) Support for New Faculty Member

$715,076
David T Scadden · Massachusetts General Hospital · P30 · FY2009 · HL

Regulation of NF-Kappa B

$714,981
Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2012 · AI

Regulation of NF-Kappa B

$714,981
Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2014 · AI

iPS cells-derived progenitor cells for angiomyogenesis

$714,954
Yigang Wang · University Of Cincinnati · R01 · FY2015 · HL

Dissecting the thermogenic adipose niche

$714,937
Yu-Hua Tseng · Joslin Diabetes Center · R01 · FY2023 · DK

Cellular and Molecular Biology at Michigan

$714,919
Robert S Fuller · University Of Michigan At Ann Arbor · T32 · FY2019 · GM

Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer

$714,896
Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer

$714,894
Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer

$714,893
Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Virtual systemic identification of drug targets of obesity candidate genes

$714,892
Yingchang Lu · Vanderbilt University Medical Center · R01 · FY2024 · DK

Genomic targets of oncoproteins and tumor suppressors

$714,829
Kevin Struhl · Harvard Medical School · R01 · FY2020 · CA

Genomic targets of oncoproteins and tumor suppressors

$714,829
Kevin Struhl · Harvard Medical School · R01 · FY2016 · CA